RESOURCES

Discover Metabolism and Safety Risks Early in Development

Translational Insights with the Speed and Ease of In Vitro Evaluation.

Translational Insights with the Speed and Ease of In Vitro Evaluation

Cytokines and Beyond—A Readout for Every Program

The GPCR Experts
Eurofins Discovery welcomes a new company to its organization, Beacon Discovery.

Polypharmacology describes the activity of compounds at multiple targets.

Protease-activated receptor 2 (PAR2) is an attractive target for the treatment of inflammation and cancer¹.

Several Bevacizumab products are approved for clinical use, with many others in late-stage clinical development worldwide.

Experimental standard deviations (error bars) are calculated for BioMAP projects when agent samples are run in triplicate, including but not limited to the Oncology Systems, Fibrosis Systems and T Cell Autoimmune Panels.

The pandemic caused by SARS-CoV-2 is expected to significantly alter the Global Health Burden, a measure of health-related impacts on world economies.

NASH (non-alcoholic steatohepatitis) is the most common and progressive non-alcoholic fatty liver disease (NAFLD) and is a major cause of liver cirrhosis, transplantation and cancer.

Pharmacology safety assessment of new chemical entities focuses on non-specific biological activities that they could possess in addition to their intended biological target.